CADL
USDCandel Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$5.030
Максимум
$5.270
Минимум
$5.030
Объем
0.50M
Фундаментальные показатели компании
Рыночная капитализация
281.6M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.77M
Биржа
NGM
Валюта
USD
52-недельный диапазон
Связанные новости
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., FMedSci, Candel's President and CEO, will present the phase 3 clinical trial of
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies
Stephens & Co. Initiates Coverage On Candel Therapeutics with Overweight Rating, Announces Price Target of $15
Stephens & Co. analyst Sudan Loganathan initiates coverage on Candel Therapeutics with a Overweight rating and announces Price Target of $15.
LifeSci Capital Initiates Coverage On Candel Therapeutics with Outperform Rating, Announces Price Target of $16
LifeSci Capital initiates coverage on Candel Therapeutics with a Outperform rating and announces Price Target of $16.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.